Two Sigma Securities’s Oncolytics Biotech ONCY Stock Holding History

Two Sigma Securities’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.8K	Buy	+25,627	New	+$25.5K	﹤0.01%	1361
2025 Q2	–	Sell	-15,159	Closed	-$8.34K	–	1922
2025 Q1	$8.34K	Buy	+15,159	New	+$11.1K	﹤0.01%	1257
2024 Q4	–	Sell	-14,079	Closed	-$12.3K	–	2763
2024 Q3	$12.3K	Buy	+14,079	New	+$13.8K	﹤0.01%	2564
2024 Q2	–	Sell	-11,816	Closed	-$12.5K	–	3459
2024 Q1	$12.5K	Sell	11,816 -11,562	-49%	-$12.9K	﹤0.01%	2735
2023 Q4	$31.6K	Buy	+23,378	New	+$36.5K	﹤0.01%	2657
2022 Q3	–	Sell	-20,512	Closed	-$21K	–	2955
2022 Q2	$21K	Buy	+20,512	New	+$24.9K	﹤0.01%	1953
2022 Q1	–	Sell	-27,125	Closed	-$38K	–	2389
2021 Q4	$38K	Buy	+27,125	New	+$50.1K	﹤0.01%	1317

Other funds holding ONCY

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Securities's ONCY Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Oncolytics Biotech (ONCY) in Q1 2026: 25,627 shares worth $21.8K. The stake represents ﹤0.01% of the portfolio and ranks #1361 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ONCY as recently as Q1 2025.

Two Sigma Securities first reported a position in ONCY in Q4 2021 and has held it in 7 quarters since. The position peaked at $38K in Q4 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

Two Sigma Securities held 25,627 shares of Oncolytics Biotech worth $21.8K as of Q1 2026.
Oncolytics Biotech was a new Two Sigma Securities position in Q1 2026.
Oncolytics Biotech made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1361 holding.
Two Sigma Securities first reported a position in Oncolytics Biotech in Q4 2021 and has held it in 7 quarters since.
Two Sigma Securities's Oncolytics Biotech position peaked at $38K in Q4 2021.
59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.